At a glance
ClinicalIndex Comparison RecordN/ACompleted· 148 enrolled
Drug / intervention
Restylane Defynedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Restylane Defyne for Correction of Chin Retrusion
In Brief
A clinical study evaluating Restylane Defyne for Chin Retrusion. Completed, enrolled 148 participants across 1 site.
Detailed Summary
This is a randomized, evaluator-blinded, no-treatment controlled study in subjects with Chin Retrusion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChin Retrusion
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 2018
Enrollment StartOct 2018
Primary CompletionSep 2019
Study CompletionSep 2020
TodayJul 2026
First PostedJul 24, 2018
Enrollment StartOct 8, 2018
Primary CompletionSep 24, 2019
Study CompletionSep 9, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.9 years ago
Interventions
Restylane Defynedevice
Intradermal injection